Navigation Links
Ruling enforces international trademark electronic filing requirements

Businesses could lose important trademark rights by failing to meet the technical filing requirements of the U.S. Patent and Trademark Office and the Trademark Trial and Appeal Board, as demonstrated by an international case of earlier this year.

In the case, In re Borlind Gesellschaft for kosmetische Erzeugnisse mbH, the Trademark Trial and Appeal Bo......

Full article >>> ed States, the PTO had to change the rules for filing oppositions or requests for extensions of time to file oppositions to Madrid Protocol applications and require that they be filed electronically via ESTTA. Electronic filings can be processed almost immediately by the PTO, whereas paper filings can take weeks or even months to be collected and reviewed.

In re Borlind illustrates......

Full article >>> l continue to be challenged with the task of keeping up with the resulting changes to PTO rules. Significantly, despite the result in In re Borlind, issued in January, there have been at least three subsequent TTAB decisions where the board has had to deny requests for extension of time to oppose Madrid Protocol applications because the potential opposer had failed to use the electronic fil......

Full article >>>
'"/>

Source:wistechnology.com By Ariana Voight 10/12/05


Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. 30 days to success: Three simple steps to create your own international startup
4. Internet trademark war goes international
5. Lack of broadband hamstrings international videoconferencing
6. Wisconsin business leads small delegation to international BIO Conference
7. Early Stage, Step 4: Cautionary trademark tales
8. SC Johnson issues trademark warning over web offer
9. NameProtect releases annual list of top trademarkers
10. Why file for trademark protection?
11. Global branding is easy with global trademarks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/28/2017)... ... ... Executive search firm, Slone Partners, announces the placement of ... distinguished life sciences expert with a proven track record in strategic global business ... of services related to laboratory testing and analysis for the pharmaceutical, medical device, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the fight against cancer, autoimmune disease and more through a single-cell precision engineering ... and proteomics analysis platform developed in the laboratory of Dr. James Heath ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... generally produce small, heterogeneous samples with limited tumor content in a large background ... be resolved, such as the need for reliable detection of low abundance somatic ...
Breaking Biology Technology:
(Date:3/1/2017)... 1, 2017  Aware, Inc. (NASDAQ: AWRE), a leading ... Richard P. Moberg has resigned, effective March 3, ... Financial Officer and Treasurer of Aware citing a desire ... a member of the Board of Directors of Aware. ... Executive Officer and co-President, General Counsel has been named ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
Breaking Biology News(10 mins):